{
    "clinical_study": {
        "@rank": "127680", 
        "arm_group": [
            {
                "arm_group_label": "Intervention Group I", 
                "arm_group_type": "Active Comparator", 
                "description": "Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture I"
            }, 
            {
                "arm_group_label": "Interventional Group II", 
                "arm_group_type": "Active Comparator", 
                "description": "Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture II"
            }, 
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Regular non-hydrolysed cow's milk based infant formula"
            }, 
            {
                "arm_group_label": "Reference Group", 
                "arm_group_type": "No Intervention", 
                "description": "Exclusively breast-fed infants"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is initiated to investigate the effect of infant formula with added specific\n      synbiotics mixture on proportion of beneficial bacteria."
        }, 
        "brief_title": "Color Synbiotics Study", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Beneficial Bacteria in Gut", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy term infants (gestational age \u2265 37 1/7 and \u2264 41 6/7 weeks) aged 46 - 65 days\n             (inclusive) at entry into the study\n\n          -  Fully formula fed for at least one week (not applicable for the breastfeeding\n             reference group since these infants must be exclusively breastfed before and\n             throughout the study)\n\n          -  Parents' or legal guardian's written informed consent\n\n        Exclusion Criteria:\n\n          -  Exclusion criteria for run-in period (visit 1, screening) are:\n\n          -  Being weaned before inclusion (introduction of any other foods other than formula or\n             human milk)\n\n          -  Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2\n             z-scores of the median WHO growth standards\n\n          -  Medical condition for which a special diet other than standard (non hydrolised) cow's\n             milk-based infant formula is required\n\n          -  Known congenital diseases or malformations which could interfere with the study (e.g.\n             gastrointestinal malformations, congenital immunodeficiency), as per investigator's\n             clinical judgement\n\n          -  Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks prior to entry into\n             the study\n\n          -  Received Inactivated Poliovirus Vaccine (IPV) or Rotavirus Vaccine (RV) prior to\n             entry into the study\n\n          -  Gastroenteritis or diarrhoea in the last two weeks prior to entry into the study\n\n          -  Participation in any other studies involving investigational or marketed products\n             concomitantly or within two weeks prior to entry into the study\n\n          -  Investigator's uncertainty about the willingness or ability of the parents to comply\n             with the protocol requirements"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Days", 
            "minimum_age": "43 Days"
        }, 
        "enrollment": {
            "#text": "172", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01813175", 
            "org_study_id": "COL.1.C.A"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intervention Group I", 
                "description": "Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture I", 
                "intervention_name": "Regular non-hydrolysed cow's milk I", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Interventional Group II", 
                "description": "Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture II", 
                "intervention_name": "Regular non-hydrolysed cow's milk II", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control Group", 
                "description": "Regular non-hydrolysed cow's milk based infant formula without synbiotics mixture", 
                "intervention_name": "Regular non-hydrolysed cow's milk - control", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 13, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Sungkorn Jongpiputvanich, A/Prof"
                }, 
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand"
                    }, 
                    "name": "King Chulalongkorn Memorial Hospital"
                }, 
                "investigator": {
                    "last_name": "Sungkorn Jongpiputvanich, A/Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nopaorn Phavichitr, Dr"
                }, 
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand"
                    }, 
                    "name": "Phramongkutklao Hospital"
                }, 
                "investigator": {
                    "last_name": "Nopaorn Phavichitr, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "4", 
        "official_title": "Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Synbiotics Mixtures on Gut Microbiota Composition in Healthy Infants.", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Thailand: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change of Baseline proportion of beneficial bacteria at week 6 in interventional group compared to the change in control group", 
            "safety_issue": "No", 
            "time_frame": "baseline, week 6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01813175"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change of proportion of baseline beneficial bacteria at week 6 in interventional group I compared to the change in control group", 
                "safety_issue": "No", 
                "time_frame": "baseline, week 6"
            }, 
            {
                "measure": "Change of Baseline proportion of beneficial bacteria at week 6 in interventional group II compared to the change in control group", 
                "safety_issue": "No", 
                "time_frame": "baseline, week 6"
            }
        ], 
        "source": "Danone Asia Pacific Holdings Pte, Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Danone Asia Pacific Holdings Pte, Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}